Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Healthtrust
US Army
Argus Health
Novartis
Queensland Health
QuintilesIMS
Moodys
Cerilliant
Teva

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204153

« Back to Dashboard

NDA 204153 describes LUZU, which is a drug marketed by Medicis and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug. Additional details are available on the LUZU profile page.

The generic ingredient in LUZU is luliconazole. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the luliconazole profile page.
Summary for 204153
Tradename:LUZU
Applicant:Medicis
Ingredient:luliconazole
Patents:5
Pharmacology for NDA: 204153
Ingredient-typeAzoles
Mechanism of ActionCytochrome P450 2C19 Inhibitors
Suppliers and Packaging for NDA: 204153
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LUZU luliconazole CREAM;TOPICAL 204153 NDA Oceanside Pharmaceuticals 68682-850 N 68682-850-60
LUZU luliconazole CREAM;TOPICAL 204153 NDA Valeant Pharmaceuticals North America LLC 99207-850 N 99207-850-60

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength1%
Approval Date:Nov 14, 2013TE:RLD:Yes
Regulatory Exclusivity Expiration:Nov 14, 2018
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:➤ Sign UpPatent Expiration:Jan 18, 2020Product Flag?YSubstance Flag?YDelist Request?
Patent:➤ Sign UpPatent Expiration:Apr 28, 2034Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
UBS
Julphar
Cantor Fitzgerald
Medtronic
Citi
Chinese Patent Office
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot